The emerging treatment of tirzepatide peptide represents a major breakthrough in the management of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets two pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide148538.ampblogs.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-79062537